Two cases of parkinsonism with atypical genetics
Objective: To report and discuss two unrelated patients carrying heterozygous mutations in both Parkin (PARK2) and Glucocerebrosidase (GBA) gene, with atypical Parkinsonian features. Background: Parkin…Relationship between sensory augmentation and exercise routine in the improvement in balance and gait in a patient with lithium-induced ataxia
Objective: This case report describes the use of sensory augmentation and an exercise routine to improve balance and gait in a patient with lithium-induced ataxia.…Brain mechanisms underlying visual processing in Parkinson’s disease
Objective: We used fMRI and a visual cognitive task to study brain mechanisms underlying visual processing at different cognitive loads in patients with PD and…Parkinson’s disease patients with onset in right side have a worse cognitive prognosis
Objective: The our intention was to investigate a dynamics of cognitive decline in patients with different side of onset parkinsonism in view of visual dysfunction…Treatment and diagnosis with the use of neuropsychological scale in patients with posttraumatic subcortical Parkinsonian dementia
Objective: To study the value of various neuropsychological scales to determine the degree of cognitive dysfunction in patients with posttraumatic subcortical Parkinsonian dementia, during the…Assessment of humor in Parkinson’s disease and the effect of deep brain stimulation
Objective: To assess humor perception in Parkinson's disease (PD) patients by comparison to a matched sample of healthy controls (HC), and to investigate the effects…Association between cognitive status and mobility performance in dual task condition in patients with Parkinson’s disease
Objective: To analyzed the association of cognitive status (CS) and mobility performance in dual task conditions in Parkinson's disease patients (PDP) and to assess the…The effect of statin use on cognition in Parkinson’s disease
Objective: To evaluate the effect of statin (HMG CoA reductase inhibitor) use on 1) baseline cognition; 2) rate of cognitive decline; and 3) conversion from…Cognitive function and self-reported depressive symptoms in a population-based cohort to study non-motor-symptoms of Parkinson’s disease
Objective: To describe the relation of depressive symptoms with cognitive performance in our cohort at baseline and two-year follow-up. Background: Cognitive function (CF) is frequent…A randomized clinical trial of atomoxetine treatment for mild cognitive impairment (MCI) in Parkinson’s disease (PD)
Objective: To evaluate (1) safety and tolerability of ATM and (2) effects of ATM on attention and executive functioning in PD- MCI after 10 weeks…
- « Previous Page
- 1
- …
- 110
- 111
- 112
- 113
- 114
- …
- 117
- Next Page »